| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |